Eagle Pharmaceuticals (NASDAQ:EGRX): Q4 Non-GAAP EPS of $0.48 misses by $0.01; GAAP EPS of $0.07 beats by $0.14.
Revenue of $48.26M (-13.9% Y/Y) misses by $0.82M.
https://seekingalpha.com/news/3547312-eagle-pharmaceuticals-eps-misses-0_01-misses-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.